Sanyal Biotechnology is a Contract Research Organization (CRO) with proprietary technology used to screen drugs for pharmaceutical companies. Pharmaceutical companies pay us to accelerate their preclinical drug development in the areas of metabolic syndrome and related liver diseases (NASH, NAFLD). Using our proprietary animal model, the DIAMOND(tm) mice, we determine which compounds are most likely to succeed in human clinical trials.